Pamela Ohashi

Researcher

Related Research

Related News & Events

Research Highlight|October 30, 2024

No tumour sample, no problem: Blood test predicts immunotherapy outcomes without biopsy

A blood test developed by Terry Fox-funded researchers has shown the potential to predict how patients with various types of cancer will respond to im...

Research Highlight|February 10, 2022

Gut bacteria linked to immune suppression in pancreatic cancer: Study

Lactobacillus – a type of bacteria thought to promote gut health – can alter the function of immune cells called macrophages in the pancreatic tumour ...

Research Highlight|September 10, 2021

New study helps understand who will benefit from immunotherapy

TFRI-funded researchers at the Princess Margaret Cancer Centre in Toronto have made findings which help expand understanding of which patients will be...

Research Highlight|August 04, 2020

A blood test could predict who benefits from immunotherapy

A test which detects changing levels of tumour fragments in the blood may be an easy, non-invasive and quick way to predict who will benefit from immu...

Research Highlight|May 27, 2020

Promising new antigens found in non-coding ovarian cancer DNA may provide clues for therapeutic vaccine

Ovarian cancer researchers in Montreal are hoping newly found molecules might be used to create vaccines for patients with an aggressive form of the d...

Research Highlight|April 20, 2020

Pancreatic cancer researchers encouraged by new T-cell finding that identifies patients with hallmarks of an antitumour response

A small subset of patients with pancreatic cancer exhibit a T-cell inflamed profile, a finding that could open the door for the potential use of immun...

Research Highlight|October 04, 2019

Early results from two studies provide insight into who may benefit from immunotherapies

Two recent studies partly funded by the TFRI are showing results that provide key insights into how immunotherapy works, and who may benefit from it.

Research Highlight|June 01, 2018

Harmonizing T-cell production across multiple Canadian sites will potentially bring immunotherapy trials to more patients in more places

Ovarian cancer patients across Canada may soon have access to promising immunotherapy trials thanks to a new collaboration fostered by The Terry Fox C...

Press Release|September 07, 2016

TFRI ANNOUNCES 2016 FUNDING COMPETITION AWARD RECIPIENTS

Vancouver, BC – Six outstanding Canadian research teams will use $27.3 million in new funding to engineer precision medicines for patients whose cance...

All News & Events